Status:
COMPLETED
The Utility of Peri-operative Arnica Montana for Reduction of Ecchymosis in Rhinoplasty Surgery
Lead Sponsor:
University of Wisconsin, Madison
Conditions:
Ecchymosis
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
Arnica montana is a homeopathic drug that is made in accordance with the official methods of the Homeopathic Pharmacopoeia of the United States (HPUS) and is commonly used by cosmetic surgeons through...
Detailed Description
Subjects will receive either oral arnica montana or placebo without any identifying labels or markers on the drugs. During the post-operative period, the patients will be seen back in surgery clinic ...
Eligibility Criteria
Inclusion
- Adult patients who are deemed candidates for rhinoplasty surgery at UW Transformations will be eligible to participate in the study.
- \-
Exclusion
- Patients who are prisoners
- Patients who are pregnant and breast-feeding women
- Patients taking anti-coagulants (such as blood thinners), anti-platelet drugs (such as NSAIDS), or other homeopathic remedies during the peri-operative period
- Patients with a bruising or bleeding disorder
- Patients who take oral corticosteroid therapy
- Patients who suffer from severe liver or kidney disease
- Patients with malignancy, infection, immunodeficiency, metabolic syndrome, infectious or inflammatory gastrointestinal disease
- Patients with oral or contact allergies to Arnica montana or to any other member of the Asteraceae family of plants such as ragweed, chrysanthemums, marigolds, and daisies
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT01164644
Start Date
June 1 2010
End Date
December 1 2012
Last Update
May 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin-Madison
Madison, Wisconsin, United States, 53792